Quantcast

Latest Morphinans Stories

2014-06-03 08:32:29

Multi-Tranche Financing Provides Sufficient Funding to Take KP201 Through and Beyond Potential FDA Approval and Enables KemPharm to Advance its Full Pipeline of Abuse-Deterrent Prodrugs CORALVILLE, Iowa, June 3, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that it has entered into a $60 million financing agreement with an investment fund managed by...

2014-05-30 23:05:46

The Substance Abuse Help Group Organization Comments on Efforts of Study Miami, FL (PRWEB) May 30, 2014 As reported by CBS News in the article The New Face of Heroin: Today's Users Different Than Decades Ago(5/28), a recent study has found that the demographic statistic of modern-day heroin users differs from users of the 1960's. According to the study, the most significant difference was found in gender and location. While both young men and women living in suburban and rural...

2014-05-28 08:32:01

Controlled Substance Analgesic Combination Product Uses Depomed's Proprietary Acuform® Technology NEWARK, Calif., May 28, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) announced today that the U. S. Food and Drug Administration (FDA) has accepted for filing a New Drug Application (NDA) from Mallinckrodt (NYSE: MNK) for MNK-155. MNK-155 is an investigational extended-release oral formulation of hydrocodone and acetaminophen that has been studied for the management of moderate to...

2014-05-27 08:29:52

ALISO VIEJO, Calif., May 27, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced completion of patient enrollment in the company's phase II, placebo controlled study testing AVP-923 for the treatment of agitation in Alzheimer's disease patients. Top-line results from this study are expected late September/early October. http://photos.prnewswire.com/prnvar/20130207/LA55901LOGO "Final completion of enrollment in this study is an important milestone for...

2014-05-21 23:10:53

Healthesystems clinicians assembled a valuable resource for workers’ compensation payers to share with prescribers who are treating patients for chronic pain with opioid therapy. Tampa, Fla. (PRWEB) May 21, 2014 Implementation of an aggressive opioid management strategy that includes opioid dose tapering can minimize risks to injured workers and workers’ compensation claims organizations. Long-term opioid therapy carries significant risks and can lead to complex, escalating and...

2014-05-21 08:28:20

- Rapid and effective relief for all racehorses in study MELBOURNE, Australia, May 21, 2014 /PRNewswire/ -- A Phosphagenics Limited (ASX:POH, OTCQX: PPGNY) study using its TPM(®)/Oxycodone topical patch to manage shin soreness pain for thoroughbred racehorses found recovery from pain in all horses within 1-2 days. The study was conducted on six thoroughbreds, between two and three years of age, exhibiting cannon (shin) bone soreness arising from injuries in either one or two...

2014-05-19 08:28:11

RICHMOND, Va., May 19, 2014 /PRNewswire/ -- Reckitt Benckiser Pharmaceuticals Inc. (RBP) announced today that it has entered into a definitive agreement with AntiOp, Inc. to co-develop a naloxone nasal spray to aid in the reversal of opioid overdose with the option to acquire all rights to the product upon receipt of regulatory and marketing approval. The product has the potential to be the first of its kind to treat overdose from opioid prescription painkillers and heroin - a growing...

2014-05-13 23:04:47

TreatmentHelp, drug and rehabilitation website, identifies five states that have gained notoriety for its rising heroin-related problems. Delray Beach, FL (PRWEB) May 13, 2014 For the last 2 decades, heroin has been slowly yet surely plaguing the United States. Death rates resulting from heroin use have been increasing among all age groups. Heroin has also gained notoriety as being the cause of death among talented celebrities such as Janis Joplin, River Phoenix, Philip Seymour Hoffman,...

2014-05-13 16:29:25

DUBLIN, May 13, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Mallinckrodt Inc.'s Exalgo(®) (Hydromorphone Hydrochloride Extended-release Tablets 8 mg, 12 mg and 16 mg). Actavis intends to begin shipping its product shortly and believes that, under applicable Hatch Waxman rules, it may be entitled to marketing exclusivity....

Researchers Combine Graphene And Painkiller Receptor
2014-05-13 03:09:16

University of Pennsylvania Almost every biological process involves sensing the presence of a certain chemical. Finely tuned over millions of years of evolution, the body’s different receptors are shaped to accept certain target chemicals. When they bind, the receptors tell their host cells to produce nerve impulses, regulate metabolism, defend the body against invaders or myriad other actions depending on the cell, receptor and chemical type. Now, researchers from the University of...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related